Virtus LifeSci Biotech Clinical Trials ETF (BBC): Price and Financial Metrics ETF
BBC Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $25.38 | 52-week high | $31.99 |
| Prev. close | $25.74 | 52-week low | $16.88 |
| Day low | $25.38 | Volume | 200 |
| Day high | $25.48 | Avg. volume | 3,948 |
| 50-day MA | $28.48 | Dividend yield | 0.29% |
| 200-day MA | $23.35 |
BBC Stock Price Chart Interactive Chart >
Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF Bio
The investment objective of the Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. The clinical trials index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.
BBC ETF Info
| Issuer | Virtus ETF Advisors LLC |
| Expense Ratio | 0.79% |
| Underlying Index | LifeSci Biotechnology Clinical Trials Index |
| Asset Class | Portfolio-Multi Asset |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 11.50M |
| Net Asset Value (NAV) | $28.76 |
| Options? | Yes |
| Total Holdings | 107 |
BBC Top Holdings
| Symbol | Company | % of Total |
| VKTX | Viking Therapeutics Inc | 2.93% |
| ALPN | Alpine Immune Sciences Inc | 2.83% |
| RNA | Avidity Biosciences Inc | 2.47% |
| VERA | Vera Therapeutics Inc | 2.4% |
| SANA | Sana Biotechnology Inc | 1.75% |
| DYN | Dyne Therapeutics Inc | 1.73% |
| CGEM | Cullinan Oncology Inc | 1.69% |
BBC Price Returns
| 1-mo | -11.35% |
| 3-mo | 6.25% |
| 6-mo | 45.21% |
| 1-year | 7.61% |
| 3-year | -46.56% |
| 5-year | -6.80% |
| YTD | 3.79% |
| 2023 | -1.80% |
| 2022 | -35.13% |
| 2021 | -22.31% |
| 2020 | 30.32% |
| 2019 | 63.81% |
BBC Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||